Add BrightSurf on Google Email

EMBO


Ten group leaders awarded EMBO Installation Grants

Ten life scientists have been awarded EMBO Installation Grants to establish laboratories in Croatia, Czechia, Estonia, Greece, Poland and Portugal. The grants support research projects on various topics including protein quality control and myeloid cell heterogeneity.

SourceEMBO·DateJan 21, 2025

Twenty-seven scientists become EMBO Young Investigators

EMBO has announced the selection of 27 young scientists to join its prestigious Young Investigator Programme, with projects spanning cell and computational biology, immunology, neuroscience, and more. The programme supports innovation and collaboration among new leaders in life sciences.

SourceEMBO·DateDec 3, 2024

When muscles inexorably shrink

Researchers found that iron supplementation can sustain muscle function, mass, and survival in mouse models of colon cancer. In humans, a small group experienced moderate strength improvement after iron injection, suggesting potential benefits for cachexia sufferers.

SourceEMBO·JournalEMBO Reports·TypeExperimental study·DateFeb 24, 2022

Metabolic memory plays a key role in breast cancer relapse

A study published in Molecular Systems Biology reveals that tumour cells resistant to treatment exhibit 'metabolic and epigenetic memory' of the tumour state. This finding highlights the importance of glycolysis in sustaining cellular metabolism and provides a potential therapeutic target for preventing breast cancer recurrence.

SourceEMBO·JournalMolecular Systems Biology·TypeData/statistical analysis·DateOct 25, 2021

EMBO Gold Medal 2021 awarded to Andrea Ablasser

Andrea Ablasser is awarded the EMBO Gold Medal 2021 for her groundbreaking research on how cells recognize double-stranded DNA as a danger signal. Her work may pave the way for therapeutic opportunities for inflammatory conditions and cancer treatment.

SourceEMBO·DateJun 15, 2021

Biomarkers could help predict severe SARS-CoV-2 infection

Researchers discovered biomarkers associated with COVID-19 immunopathology and multi-organ damage, enabling early identification of patients at risk of severe symptoms. The study's findings have potential for developing prognostic classification models to target treatments accordingly.

SourceEMBO·JournalThe EMBO Journal·DateDec 14, 2020

Naturally occurring antibodies against prion proteins found in humans

Scientists have found that a small proportion of individuals possess high levels of antibodies targeting the normal PrP version of the prion protein. These antibodies may be beneficial in targeting pathological aggregates for degradation by phagocytic cells, potentially offering new tools for studying neurodegeneration. The discovery s...

SourceEMBO·JournalEMBO Molecular Medicine·DateAug 17, 2020

Review Commons, a pre-journal portable review platform

Review Commons, launched by ASAPbio and EMBO Press, enables high-quality pre-journal peer review of manuscripts from the life sciences. This platform empowers authors to make informed decisions on paper submission and expedites submission to affiliate journals without restarting reviews.

SourceEMBO·JournalThe EMBO Journal·DateDec 9, 2019

Exploring drug repurposing to treat glioblastoma

Researchers found that MALT1 levels correlate with patient survival in brain cancer, and blocking the gene with MALT1 inhibitors causes glioblastoma stem cells to undergo cellular suicide. This discovery points to the potential of further exploring MALT1 inhibitors as a treatment for glioblastoma.

SourceEMBO·JournalThe EMBO Journal·DateNov 27, 2019

Strategies of a honey bee virus

Scientists analyzed the virus' course of action and discovered how it captures host ribosomes using a structured RNA sequence called IRES. This finding advances research into feeding bees RNA molecules that interfere with the virus's RNA, potentially offering a solution to Colony Collapse Disorder.

SourceEMBO·JournalThe EMBO Journal·DateOct 23, 2019

Towards a blood test for early-stage liver disease

Researchers have identified six proteins associated with early-stage non-alcoholic fatty liver disease (NAFLD), a condition that can progress to end-stage liver cirrhosis. The discovery of protein PIGR as a candidate biomarker for liver damage tests offers a promising new diagnostic tool.

SourceEMBO·JournalMolecular Systems Biology·DateMar 1, 2019

A role for microRNAs in social behavior

A study discovered that a microRNA cluster regulates synaptic strength and is involved in controlling social behavior in mammals. The researchers found that the absence of this microRNA cluster results in increased sociability in mice.

SourceEMBO·JournalEMBO Reports·DateDec 14, 2018

Towards a treatment for gluten intolerance

A new study has identified a specific peptide that directly binds to the ion-channel CFTR, impairing its function and triggering cellular stress and inflammation. This interaction can be inhibited by a potentiator of CFTR, which may offer protection against gluten-induced intestinal symptoms.

SourceEMBO·JournalThe EMBO Journal·DateNov 30, 2018

A gene required for addictive behavior

Researchers found that mice lacking the Maged1 gene are unresponsive to cocaine and show diminished dopamine release, highlighting its role in addictive behavior. The study provides new insights into the molecular mechanisms underlying drug addiction.

SourceEMBO·JournalEMBO Reports·DateJul 12, 2018

Tailoring blood cells in the laboratory

Scientists have engineered red blood cell lines to express fewer antigens, making them less immunogenic for patients with rare blood types. This breakthrough could lead to the development of more universal blood sources for transfusion patients.

SourceEMBO·JournalEMBO Molecular Medicine·DateApr 26, 2018

How to hijack degrading complexes to put cancer cells asleep

Researchers found that palbociclib induces substantial changes in the proteasome, degrading proteins required for cell cycle progression and driving cells into senescence. The discovery suggests that proteasomal activity may be an additional mechanism by which palbociclib stalls proliferation.

SourceEMBO·JournalThe EMBO Journal·DateApr 23, 2018

SourceData is making data discoverable

SourceData provides a suite of tools to generate, validate and use figure data, making it efficient to find and reuse published results. The platform links figures to other related figures across papers and journals, creating a searchable knowledge graph.

SourceEMBO·JournalNature Methods·DateOct 31, 2017

From a memory too strong to a memory too weak

Researchers at the University Medical Center Goettingen identified a molecular link between PTSD and Alzheimer's disease, specifically Formin 2. Formin 2 mutant mice show PTSD phenotypes at an early age and develop age-related memory decline.

SourceEMBO·JournalThe EMBO Journal·DateAug 2, 2017

Are tumor cells glutamine addicts?

Researchers found that tumor cells entering a reversible state of proliferation arrest when glutamine is depleted, rather than dying. c-MYC levels are down-regulated upon glutamine deprivation, suggesting it couples transcription to nucleotide availability.

SourceEMBO·JournalThe EMBO Journal·DateApr 13, 2017

Targeting a tumor trigger

Researchers have devised a strategy to specifically target cancer stem cells in some cancers and reduce their tumor-generating potential. Combining Nutlin-3 and Paclitaxel showed potentiated tumor response and prevented relapse in Numb-deficient tumors, suggesting the potential of these drugs as treatment options.

SourceEMBO·JournalEMBO Molecular Medicine·DateMar 15, 2017

A closer look at brain organoid development

Researchers have characterized cerebral organoids, showing they recapitulate human brain developmental processes and involve forebrain organizing centers. These findings advance our understanding of normal organoid development and are essential for modeling human developmental diseases.

SourceEMBO·JournalThe EMBO Journal·DateMar 10, 2017

The genetics behind being Not Like Daddy

A study by Laurine Gilles and colleagues sheds light on the genetics behind haploid induction in maize, revealing the molecular identity of a key gene that promotes fertilization. The identification of 'Not Like Dad' is an important breakthrough to fully understand the process and translate this breeding tool to other crops.

SourceEMBO·JournalThe EMBO Journal·DateFeb 22, 2017

Remembering where to get high

A study published in The EMBO Journal found that cocaine-induced place preference in mice is independent of lasting NAc neuronal rewiring. Silent synapse formation and unsilencing during withdrawal are essential for many addictive behaviors but not for this specific behavior.

SourceEMBO·JournalThe EMBO Journal·DateJan 11, 2017

Rejuvenating the brain's disposal system

A new tissue culture system has revealed that microglia from aged brains are engulfing amyloid plaques on site, with young microglia secreting factors to rejuvenate older cells. The discovery highlights a potential strategy for removing amyloid plaques and improving cognition in Alzheimer's disease.

SourceEMBO·JournalThe EMBO Journal·DateDec 21, 2016

Richard Benton and Ben Lehner awarded EMBO Gold Medal 2016

Researchers Richard Benton and Ben Lehner received the 2016 EMBO Gold Medal for their groundbreaking work on insect olfaction and developmental biology. They discovered novel genes in odorant receptors, shedding light on the evolution of scent perception, and revealed stochastic variances in gene expression driving phenotypic diversity.

SourceEMBO·DateMay 25, 2016

A new biomarker of brain inflammation in early-stage Alzheimer's disease

A new biomarker of brain inflammation in early-stage Alzheimer's disease has been identified, indicating that microglia-mediated inflammation may demarcate the transition from preclinical to full dementia. The TREM2 protein fragment in cerebrospinal fluid levels closely mirror microglia activity during the course of the disease.

SourceEMBO·JournalEMBO Molecular Medicine·DateMar 3, 2016

Wbp2 is a novel gene implicated in deafness

Researchers discovered a direct link between Wbp2 and progressive high-frequency hearing loss in mouse models and human clinical cases. The study found that Wbp2 expression loss leads to reduced hormone receptor expression and hearing impairment.

SourceEMBO·JournalEMBO Molecular Medicine·DateFeb 8, 2016

2016 Louis-Jeantet Prize for Medicine

Andrea Ballabio and John Diffley receive the 2016 Louis-Jeantet Prize for Medicine for their pioneering work on lysosomal function and its significance in diseases such as neurodegenerative disorders, cancer, and obesity. Their research could lead to new therapeutic tools for treating human diseases.

SourceEMBO·DateJan 20, 2016

Molecular trigger for Cerebral Cavernous Malformation identified

Researchers have identified the KLF4 protein as a crucial regulator in the development of Cerebral Cavernous Malformation (CCM), a disease characterized by vascular lesions that can lead to cerebral hemorrhage. The study suggests that blocking the development and progression of CCM could prevent mortality due to brain hemorrhage.

SourceEMBO·JournalEMBO Molecular Medicine·DateNov 26, 2015

Switching on paternal behavior

A study in mice reveals that specific brain areas control paternal versus infanticidal behavior. The activation patterns of these areas determine whether a male mouse will show caring or aggressive behavior towards newborn pups. This discovery could have implications for understanding societal problems such as child-directed aggression...

SourceEMBO·JournalThe EMBO Journal·DateSep 30, 2015